Enhanced Indolinone Based Protein Kinase Inhibitors
申请人:Liang Congxin
公开号:US20100267719A1
公开(公告)日:2010-10-21
Alpha-hydroxy-omega-(2-oxo-indolylidenemethyl-pyrrole-3′-carbonyl)amino alkanoic acid and amide derivatives have enhanced and unexpected drug properties as inhibitors of protein kinases and are useful in treating disorders related to abnormal protein kinase activities such as cancer.